Liangyu He

Liangyu He

Auto-generated profile, based on publicly available information

Liangyu He

Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning 530021, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2012
Verified
Conference Paper
Closed access
PDF file
LHLiangyu He
Liangyu He
ADAngela Davies
Angela Davies
CEC J Evans
C J Evans
The structure function (SF) represents the average height difference squared as a function of separation. The linear SF has been used in astronomy and captures data of all spatial frequencies. However, it does not capture anisotropy on the surface. The one-quadrant area SF has been introduced to represent surface roughness information, but it is inadequate when surfaces are rotationally varying, as is frequently the case for optical surfaces. The recently introduced twoquadrant representation of the area SF can be calculated for any aperture shape, for all spatial content and isotropies. This paper describes the physical interpretation of the two-quadrant area SF and the comparison to area power spectral density (PSD) and area autocorrelation function (ACF) for a range of optical surfaces.

30 January 2023 in BioMed Research International
Verified
Journal Article
Open access
PDF file
YZYushan Zhang
Yushan Zhang
LHLiangyu He
Liangyu He
LPLixin Pan
Lixin Pan
CFChao Feng
Chao Feng
XWXi Wang
Xi Wang
HUHanif Ullah
Hanif Ullah
Purpose. Hepatocellular carcinoma (HCC) is a disease with great heterogeneity and a high mortality rate. It is crucial to identify reliable biomarkers for diagnosis, prognosis, and treatment to improve clinical outcomes in patients with HCC. Alpha‐fetoprotein (AFP) is not only a widely used biomarker in clinical practice but also plays a complicated role in HCC, and it has recently been considered to be related to immunotherapy. MicroRNAs (miRNAs) are regarded as key regulators and promising biomarkers of HCC. We investigated the role of an AFP‐related miRNA, miR‐135b‐5p, in HCC progression. Methods. Identification of miR‐135b‐5p was performed based on a cohort of 65 HCC cases and the liver hepatocellular carcinoma cohort of The Cancer Genome Atlas (Asian people only). A combination of whole‐transcriptome sequencing and high‐dimensional proteomic technologies was used to study the role of miR‐135b‐5p in HCC. Results. Upregulation of miR‐135b‐5p was detected in patients with HCC with high serum AFP levels (AFP > 400 ng/ml). Elevated miR‐135b‐5p expression was associated with adverse prognosis. We also identified the relevance between high miR‐135b‐5p expression and tumor‐related pathological characteristics, such as Edmondson grade and vascular invasion. We revealed tyrosine kinase nonreceptor 1 as a potential target of miR‐135b‐5p. Additionally, the transcriptional start site of miR‐135b‐5p had potential binding sites for SRY‐box transcription factor 9, and the stemness properties of tumor cells were more remarkable in HCC with the upregulation of miR‐135b‐5p. The molecular characterization of the miR‐135b‐5p‐high group was similar to that of the HCC subclasses containing moderately and poorly differentiated tumors. Finally, gene signatures associated with improved clinical outcomes in immune checkpoint inhibitor therapy were upregulated in the miR‐135b‐5p‐high group. Conclusion. miR‐135b‐5p could be a biomarker for predicting the prognosis and antiprogrammed cell death protein 1 monotherapy response in HCC.